Biotek-snakken — Juni 2021
-
Daiichi Sankyo Reaffirms Long-term Goals with Increased Investment in ADCs » ADC Review
Daiichi Sankyo Reaffirms Long-term Goals with Increased Investment in ADCs » ADC Review
ADC Review (www.adcreview.com)
-
For at udløse SL - der bliver jo spekuleret voldsomt i aktien.
Mon ikke de får en tilladelse til salg af Sulopenem...safety og effekt ser rigtig fin ud. PDUFA mål er 25. juli, så det er lige om lidt. Gætter på fortsat stigende aktiekurs over sommeren. -
ProInvestor er desværre under massivt hacker angreb lige nu - derfor nede:(
-
Vi har nu to gange været nedlagt i dag uagtet at vores sikkerhed er helt i top. Det beklager jeg
-
-
Medix informed Saniona that it will gather the requested information and continue discussions with the committee as soon as possible, and that it fully intends to continue to pursue the process of seeking approval for tesofensine. However, Medix advised that the continuing discussions with the committee may delay the anticipated final approval decision from COFEPRIS into 2022.
-
En forsinkelse af godkendelse til 2022….vel ikke nogen katastrofe, men koster nok lidt på kursen mandag?
-
-
Iterum kan ikke lade være: https://drive.google.com/file/d/10tez59UrLVKEhp3qkLWJ3ElZAHIS1UtE/view
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind